Treatment of wild-type mice with the iNOS inhibitor N (6)- (1-iminoethyl)-L-lysine (L-NIL) prevents structural and functional alterations in the lung vasculature and alveoli and reverses emphysema and PH (127). Here, NOS2 is linked to pulmonary emphysema.